Deepak Gondaliya
Corporate Officer/Principal en Emcure Pharmaceuticals Ltd. .
Cargos activos de Deepak Gondaliya
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | 01/07/2013 | - |
Historial de carrera de Deepak Gondaliya
Antiguos cargos conocidos de Deepak Gondaliya.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | Corporate Officer/Principal | - | - |
Formación de Deepak Gondaliya.
Hemchandracharya North Gujarat University | Doctorate Degree |
Estadísticas
Internacional
India | 4 |
Operativa
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Bolsa de valores
- Insiders
- Deepak Gondaliya
- Experiencia